This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Ruprecht-Karls-Universitaet Heidelberg, Deutsches Krebsforschungszentrum, Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 23 
1 out of 159 
1 out of 20 Years Active: 2018
Title: Svitlana Grekova: Innovator in Oncolytic Virotherapy
Introduction
Svitlana Grekova is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer therapy, particularly through her innovative work in oncolytic virotherapy. With a focus on pancreatic cancer, her inventions aim to improve treatment outcomes for patients facing this challenging disease.
Latest Patents
Svitlana Grekova holds 2 patents that showcase her groundbreaking research. Her latest patents include:
1. **Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer** - This invention relates to a combination of a parvovirus and a cytokine, preferably IFN, for use in treating pancreatic cancer, especially in its terminal stages.
2. **Oncolytic virotherapy for prevention of tumor recurrence** - This patent describes a parvovirus designed to prevent the recurrence of tumors, particularly malignant brain tumors or pancreatic tumors.
Career Highlights
Throughout her career, Svitlana has worked with esteemed institutions such as Ruprecht-Karls-Universität Heidelberg and Deutsches Krebsforschungszentrum. Her research has been pivotal in advancing the understanding and treatment of cancer through innovative therapeutic approaches.
Collaborations
Svitlana Grekova has collaborated with notable colleagues, including Zahari Raykov and Jean Rommelaere. These partnerships have enriched her research and contributed to the development of her patents.
Conclusion
Svitlana Grekova's work in oncolytic virotherapy represents a significant advancement in cancer treatment. Her innovative patents and collaborations highlight her dedication to improving patient outcomes in the fight against pancreatic cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile